MEDCAC Meeting 9/15/1999 - Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma (Drugs, Biologics, and Therapeutics Panel)
Select the ’Print Complete Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.
To print an entire document, including all codes in all code groups, use the 'Need a PDF' button or the 'Print Complete Record' button.
To print only the current visible page contents, use the 'Print' button in the page header.
3:15 - 3:30 p.m.
3:30 - 4:00 p.m.
Thursday, September 16, 1999
8:00 - 8:30 a.m.
Opening Remarks - Introduction
Agenda Item: The Committee will discuss and make coverage recommendations regarding high dose chemotherapy and stem cell transplantation for the treatment of multiple myeloma.
8:30 - 10:00 a.m.
10:00 - 10:15 a.m.
10:15 - 11:30 a.m.
11:30 - 12:30 p.m.
12:30 - 2:00 p.m.
Open Committee Discussion
This Portion of the Meeting Is Open to Public Observers. Public Observers May not participate except at the Specific Request of the Chairperson.
2:00 - 2:15 p.m.
2:15 - 3:00 p.m.
Open Committee Discussion - Continued
This Portion of the Meeting Is Open to Public Observers. Public Observers May Not Participate Except at the Specific Request of the Chairperson.
3:00 - 3:30 p.m.
Open Public Session
Public Attendees Who Have Contacted the Executive Secretary Prior to the Meeting, Will Address the Panel and Present Information Relevant to the Agenda. Speakers Are Asked to State Whether or Not They Have Any Financial Involvement with Manufacturers of Any Items and Services being discussed, or with Their Competitors.
3:30 - 4:00 p.m.